Axovant Announces Dosing of First Patient in Second Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD – Associated Press

Axovant Announces Dosing of First Patient in Second Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD – Associated Press
Axovant Announces Dosing of First Patient in Second Cohort of SUNRISE-PD Phase 2 Trial of AXO-Lenti-PD  Associated PressPress release *content* from Globe Newswire. The AP news staff was not involved in its creation. ... read more
Source: Google NewsPublished on 2019-04-30